NicoleHasbrouckMD

Pediatric Hematology & Oncology • Philadelphia, PA

Physician

Join to view full profile

Are you Dr. Hasbrouck?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
34th & Civic Center Blvd
Children's Hospital Of Philadelphia
Philadelphia, PA 19104
Phone+1 215-590-1000

Fax+1 215-590-2204

Summary

Dr. Nicole Hasbrouck, MD is a pediatric hematologist/oncologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania, Maryland, and District of Columbia. She is affiliated with Children's National Hospital.

Education & Training

Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2005 - 2008
McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 2002 - 2005
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2002

Certifications & Licensure

DC State Medical License 2011 - 2024
MD State Medical License 2012 - 2013
PA State Medical License 2005 - 2012
IL State Medical License 2002 - 2005

Publications & Presentations

PubMed

9 citations
Early administration of COVID-19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacy.
Artur Belov, Yin Huang, Carlos H Villa, Barbee I Whitaker, Richard Forshee
American Journal of Hematology. 2022-06-01
30 citations
Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma.
Hyung Park, Thaddeus Tarpey, Mengling Liu, Keith Goldfeld, Yinxiang Wu
JAMA Network Open. 2022-01-04
1 citations
Dose Finding in Late-Phase Drug Development.
Lei Nie, Kyung Y Lee, Nicole Verdun, R. Angelo De Claro, Rajeshwari Sridhara
Therapeutic Innovation & Regulatory Science. 2017-05-30

Press Mentions

FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase DeficiencyNovember 14th, 2024
'It Was a Good Lesson': FDA Reconsiders CAR-T Boxed Warning on Secondary Cancers, Peter Marks SaysNovember 1st, 2024
Baltimore Is a City Heavily Impacted by Sickle Cell Disease as Awareness Day ApproachesMay 13th, 2024
Join now to see all